Theabrownin Induces Cell Apoptosis and Cell Cycle Arrest of Oligodendroglioma and Astrocytoma in Different Pathways
1Institute of Developmental and Regenerative Biology, Zhejiang Key Laboratory of Organ Development and Regeneration, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou, China.
Abstract:
Theabrownin (TB), a natural compound present in the fresh leaves of green tea, is a potential antitumor agent. However, so far whether and how TB affects glioma is unclear. In this study, we investigated the effect of TB on astroglioma and oligodendroglioma cells. Surprisingly, TB significantly reduced the viabilities of HOG and U251 cells in a dose-dependent manner, which was accompanied by the upregulation of active-Casp-3, Bax, and PTEN; meanwhile, the antiapoptotic gene Bcl-2 was downregulated. In addition, TB treatment induced cell cycle arrest at the G1 and G2/M phases in HOG and U251 cells, respectively. TB treatment caused the downregulating of c-myc, cyclin D, CDK2, and CDK4 and upregulating of p21 and p27 in the HOG cell, while TB increased P53, p21, and p27 levels and decreased the levels of cell cycle regulator proteins such as CDK and cyclin A/B in the U251 cells. Therefore, the c-myc- and P53-related mechanisms were proposed for cell cycle arrest in these two glioma cell lines, respectively. Overall, our findings indicated that TB could be a novel candidate drug for the treatment of gliomas.
Insights
Theabrownin (TB), a compound from green tea, effectively reduced glioma cell viability and induced cell cycle arrest. These findings suggest TB as a promising new drug candidate for treating gliomas.
Area of Science:
- Oncology
- Natural Products Chemistry
- Molecular Biology
Background:
- Gliomas are aggressive brain tumors with limited treatment options.
- Theabrownin (TB), a natural compound from green tea, shows potential as an antitumor agent.
- The specific effects of TB on glioma cells remain largely unexplored.
Purpose of the Study:
- To investigate the impact of Theabrownin (TB) on astroglioma and oligodendroglioma cells.
- To elucidate the molecular mechanisms underlying TB's effects on glioma cell viability and proliferation.
Main Methods:
- Treatment of HOG and U251 glioma cell lines with varying doses of TB.
- Assessment of cell viability using cell counting assays.
- Analysis of apoptosis-related proteins (active-Casp-3, Bax, Bcl-2, PTEN) via Western blotting.
- Cell cycle analysis using flow cytometry.
- Quantification of cell cycle regulatory proteins (c-myc, cyclins, CDKs, p21, p27, P53) via Western blotting.
Main Results:
- TB significantly reduced the viability of HOG and U251 cells in a dose-dependent manner.
- TB induced apoptosis by upregulating Bax, PTEN, and active-Casp-3, while downregulating Bcl-2.
- TB caused cell cycle arrest at G1 phase in HOG cells and G2/M phase in U251 cells, involving differential regulation of key cell cycle proteins.
- Mechanisms involved c-myc downregulation in HOG cells and P53 upregulation in U251 cells.
Conclusions:
- Theabrownin exhibits significant antitumor activity against glioma cells.
- TB induces glioma cell death and cell cycle arrest through distinct molecular pathways.
- TB represents a potential novel therapeutic candidate for glioma treatment.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
06:36An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
Published on: February 5, 2015
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
